【结 构 式】 |
【分子编号】62309 【品名】methyl 2-(bromomethyl)-3-nitrobenzoate 【CA登记号】98475-07-1 |
【 分 子 式 】C9H8BrNO4 【 分 子 量 】274.07086 【元素组成】C 39.44% H 2.94% Br 29.15% N 5.11% O 23.35% |
合成路线1
该中间体在本合成路线中的序号:(V)Cyclization of N-(benzyloxycarbonyl)glutamine (I) by means of CDI in refluxing THF gives 3-(benzyloxycarbonylamino)piperidine-2,6-dione (II), which is deprotected with H2 over Pd/C in ethyl acetate/4N HCl to yield 3-aminopiperidine-2,6-dione hydrochloride (III). Bromination of 2-methyl-3-nitrobenzoic acid methyl ester (IV) with NBS in CCl4 provides 2-(bromomethyl)-3-nitrobenzoic acid methyl ester (V), which is cyclized with the aminopiperidine (III) by means of triethylamine in hot DMF to afford 3-(4-nitro-1-oxoisoindolin-2-yl)piperidine-2,6-dione (VI). Finally, the nitro group of compound (VI) is reduced with H2 over Pd/C in methanol (1, 2).
【1】 Sorbera, L.A.; Castaner, J.; Bayes, M.; CC-5013. Drugs Fut 2003, 28, 5, 425. |
【2】 Muller, G.W.; Huang, S.-Y.; Chen, R.; et al.; Amino-substituted thalidomide analogs: Potent inhibitors of TNF-alpha production. Bioorg Med Chem Lett 1999, 9, 11, 1625. |
【3】 Stirling, D.I.; Muller, G.W.; Chen, R.S.-C. (Celgene Corp.); Substd. 2-(2,6-dioxopiperidin-3-yl)-phthalimides and -1-oxoisoindolines and method of reducing TNFalpha levels. EP 0925294; US 5635517; WO 9803502 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 37578 | N(2)-[(benzyloxy)carbonyl]glutamine | C13H16N2O5 | 详情 | 详情 | |
(II) | 37575 | benzyl 2,6-dioxo-3-piperidinylcarbamate | C13H14N2O4 | 详情 | 详情 | |
(III) | 37576 | 3-amino-2,6-piperidinedione;3-aminopiperidine-2,6-dione;2-amino-Glutarimide;Glutamimide;a-Aminoglutarimide | 2353-44-8 | C5H8N2O2 | 详情 | 详情 |
(IV) | 62310 | Methyl 3-nitro-o-toluate; 2-Methyl-3-nitrobenzoic acid | 59382-59-1 | C9H9NO4 | 详情 | 详情 |
(V) | 62309 | methyl 2-(bromomethyl)-3-nitrobenzoate | 98475-07-1 | C9H8BrNO4 | 详情 | 详情 |
(VI) | 62311 | 3-(4-nitro-1-oxo-1,3-dihydro-2H-isoindol-2-yl)-2,6-piperidinedione | C13H11N3O5 | 详情 | 详情 |
合成路线2
该中间体在本合成路线中的序号:(III)
【1】 Muller GW, Chen R, Saindane MT, et aL 2006. Processes for the preparation of substituted 2-(2,6-dioxopiperidirr3-yl)-l-oxoisoindolines,e.g.,Revlimid, using p-toluenesulfonic acid or base-mediated cyclization as the key step. US 2006052609 |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 66478 | (S)-5-amino-2-(((benzyloxy)carbonyl)amino)-5-oxopentanoic acid | C13H16N2O5 | 详情 | 详情 | |
(II) | 66479 | (S)-2,5-diamino-5-oxopentanoic acid | C5H10N2O3 | 详情 | 详情 | |
(III) | 62309 | methyl 2-(bromomethyl)-3-nitrobenzoate | 98475-07-1 | C9H8BrNO4 | 详情 | 详情 |
(IV) | 66480 | (R)-methyl 5-amino-2-(4-nitro-1-oxoisoindolin-2-yl)-5-oxopentanoate | C14H15N3O6 | 详情 | 详情 | |
(V) | 66481 | (R)-methyl 5-amino-2-(4-amino-1-oxoisoindolin-2-yl)-5-oxopentanoate | C14H17N3O4 | 详情 | 详情 |